Eyepoint Pharmaceuticals Inc (EYPT) — Cash Flow-to-Debt Ratio
Eyepoint Pharmaceuticals Inc (EYPT) has a Cash Flow-to-Debt Ratio of -1.15x as of September 2025, meaning its operating cash flow of $-59.35 Million could theoretically repay -1% of its total liabilities ($51.51 Million) in one year. See Eyepoint Pharmaceuticals Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Eyepoint Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2002–2024)
Historical debt coverage capacity for Eyepoint Pharmaceuticals Inc across 23 annual periods. For the full cash flow conversion analysis, see Eyepoint Pharmaceuticals Inc cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for Eyepoint Pharmaceuticals Inc (2002–2024)
Year-by-year debt coverage analysis for Eyepoint Pharmaceuticals Inc. Check EYPT cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.54x | $-126.23 Million | $81.96 Million | ▼ -7398.5% |
| 2023 | 0.02x | $1.88 Million | $88.86 Million | ▲ +102.7% |
| 2022 | -0.77x | $-65.00 Million | $83.99 Million | ▼ -22.0% |
| 2021 | -0.63x | $-50.10 Million | $78.99 Million | ▼ -221.5% |
| 2020 | -0.20x | $-14.44 Million | $73.18 Million | ▲ +77.5% |
| 2019 | -0.88x | $-56.70 Million | $64.64 Million | ▼ -140.2% |
| 2018 | -0.37x | $-21.91 Million | $59.98 Million | ▲ +90.5% |
| 2017 | -3.84x | $-20.49 Million | $5.34 Million | ▼ -152.5% |
| 2016 | -1.52x | $-16.32 Million | $10.74 Million | ▼ -232.8% |
| 2015 | 1.14x | $10.30 Million | $9.00 Million | ▲ +183.1% |
| 2014 | -1.38x | $-10.67 Million | $7.75 Million | ▼ -34.7% |
| 2013 | -1.02x | $-8.74 Million | $8.55 Million | ▲ +20.9% |
| 2012 | -1.29x | $-9.00 Million | $6.96 Million | ▼ -294.9% |
| 2011 | -0.33x | $-3.17 Million | $9.68 Million | ▼ -133.0% |
| 2010 | 0.99x | $9.90 Million | $9.97 Million | ▲ +259.6% |
| 2009 | -0.62x | $-8.44 Million | $13.56 Million | ▼ -110.9% |
| 2008 | -0.29x | $-5.14 Million | $17.44 Million | ▲ +71.9% |
| 2007 | -1.05x | $-21.21 Million | $20.21 Million | ▼ -104.2% |
| 2006 | -0.51x | $-16.14 Million | $31.40 Million | ▲ +91.4% |
| 2005 | -6.01x | $-9.34 Million | $1.56 Million | ▲ +0.0% |
| 2004 | -6.01x | $-9.34 Million | $1.56 Million | ▼ -48.9% |
| 2003 | -4.04x | $-5.44 Million | $1.35 Million | ▲ +22.4% |
| 2002 | -5.20x | $-3.06 Million | $588.38K | — |